ImmuCell Corporation (ICCC) DCF Valuation

ImmuCell Corporation (ICCC) DCF Valuation
  • ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
  • ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
  • ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
  • ✓ Aucune Expertise N'Est Requise; Facile À Suivre

ImmuCell Corporation (ICCC) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Gain mastery over your ImmuCell Corporation (ICCC) valuation analysis with our state-of-the-art DCF Calculator! Preloaded with authentic (ICCC) data, this Excel template enables you to modify forecasts and assumptions to accurately compute the intrinsic value of ImmuCell Corporation.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 13.7 15.3 19.2 18.6 17.5 18.7 20.0 21.4 22.9 24.5
Revenue Growth, % 0 11.8 25.43 -3.51 -5.9 6.95 6.95 6.95 6.95 6.95
EBITDA 1.4 1.6 2.7 .3 -2.5 .9 .9 1.0 1.0 1.1
EBITDA, % 10.43 10.74 14.12 1.88 -14.33 4.57 4.57 4.57 4.57 4.57
Depreciation 2.3 2.4 2.5 2.5 2.7 2.8 2.9 3.2 3.4 3.6
Depreciation, % 16.52 15.4 12.85 13.4 15.55 14.74 14.74 14.74 14.74 14.74
EBIT -.8 -.7 .2 -2.1 -5.2 -1.9 -2.0 -2.2 -2.3 -2.5
EBIT, % -6.09 -4.66 1.27 -11.51 -29.88 -10.17 -10.17 -10.17 -10.17 -10.17
Total Cash 8.8 7.9 10.2 5.8 1.0 7.7 8.2 8.8 9.4 10.0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 1.7 1.9 2.7 1.8 2.2
Account Receivables, % 12.23 12.15 14.14 9.7 12.51
Inventories 2.5 2.1 3.1 6.0 7.8 4.7 5.0 5.4 5.7 6.1
Inventories, % 18.35 13.64 16.06 32.52 44.71 25.06 25.06 25.06 25.06 25.06
Accounts Payable .4 .6 .7 .8 .9 .7 .8 .9 .9 1.0
Accounts Payable, % 2.93 3.93 3.87 4.25 5.01 4 4 4 4 4
Capital Expenditure -1.4 -4.1 -2.6 -4.0 -1.9 -3.1 -3.3 -3.5 -3.8 -4.0
Capital Expenditure, % -10.14 -26.55 -13.56 -21.41 -10.83 -16.5 -16.5 -16.5 -16.5 -16.5
Tax Rate, % -0.08019104 -0.08019104 -0.08019104 -0.08019104 -0.08019104 -0.08019104 -0.08019104 -0.08019104 -0.08019104 -0.08019104
EBITAT -.9 -.7 .3 -2.1 -5.2 -1.9 -2.0 -2.2 -2.3 -2.5
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -3.8 -2.0 -1.6 -5.6 -6.5 .7 -2.8 -3.0 -3.2 -3.4
WACC, % 6.32 6.31 6.32 6.32 6.32 6.32 6.32 6.32 6.32 6.32
PV UFCF
SUM PV UFCF -9.4
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -4
Terminal Value -81
Present Terminal Value -60
Enterprise Value -69
Net Debt 16
Equity Value -85
Diluted Shares Outstanding, MM 8
Equity Value Per Share -10.96

What You Will Get

  • Real ICCC Financials: Access to historical and projected data for precise valuation.
  • Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
  • Dynamic Calculations: Intrinsic value and NPV are computed automatically.
  • Scenario Analysis: Evaluate various scenarios to assess ImmuCell's future performance.
  • User-Friendly Design: Designed for professionals while remaining user-friendly for newcomers.

Key Features

  • Customizable Forecast Inputs: Adjust essential parameters such as revenue growth, EBITDA %, and capital expenditures tailored to ImmuCell Corporation (ICCC).
  • Instant DCF Valuation: Effortlessly computes intrinsic value, NPV, and other financial metrics in real-time.
  • High-Precision Accuracy: Leverages ImmuCell's actual financial data for credible valuation results.
  • Simplified Scenario Analysis: Evaluate various assumptions and analyze results with ease.
  • Efficiency Boosting Tool: Avoid the complexities of constructing intricate valuation models from the ground up.

How It Works

  • Download: Obtain the pre-prepared Excel file containing ImmuCell Corporation’s (ICCC) financial data.
  • Customize: Modify projections, such as revenue growth, EBITDA %, and WACC.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Develop various forecasts and instantly compare the results.
  • Make Decisions: Utilize the valuation findings to inform your investment approach.

Why Choose This Calculator for ImmuCell Corporation (ICCC)?

  • Comprehensive Tool: Offers DCF, WACC, and financial ratio analyses tailored for ImmuCell Corporation (ICCC).
  • Customizable Inputs: Modify yellow-highlighted cells to explore different financial scenarios for ImmuCell Corporation (ICCC).
  • Detailed Insights: Automatically computes ImmuCell Corporation’s (ICCC) intrinsic value and Net Present Value.
  • Preloaded Data: Historical and projected data provide reliable starting points for analysis.
  • Professional Quality: Perfect for financial analysts, investors, and business consultants focusing on ImmuCell Corporation (ICCC).

Who Should Use This Product?

  • Professional Investors: Develop comprehensive and accurate valuation models for portfolio assessments of ImmuCell Corporation (ICCC).
  • Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within their organizations.
  • Consultants and Advisors: Deliver precise valuation insights to clients focused on ImmuCell Corporation (ICCC) stock.
  • Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling.
  • Biotech Enthusiasts: Gain insights into how biotechnology companies like ImmuCell Corporation (ICCC) are appraised in the market.

What the Template Contains

  • Pre-Filled Data: Includes ImmuCell Corporation's historical financials and forecasts.
  • Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
  • Key Financial Ratios: Analyze ImmuCell Corporation's profitability, efficiency, and leverage.
  • Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
  • Clear Dashboard: Charts and tables summarizing key valuation results.

No products were found matching.